Franchi Jean M. (CIK 1653053) reported 13 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-15). Recent activity: Sell IRON (400 shares), Sell IRON (6,257 shares), Sell IRON (353 shares), Sell IRON (4,075 shares), Sell IRON (3,397 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-15 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Sell | 400 | $27,600 |
| 2026-04-15 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Sell | 6,257 | $433,234 |
| 2026-02-27 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Sell | 353 | $24,378 |
| 2026-02-19 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Sell | 4,075 | $256,154 |
| 2026-02-19 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Sell | 3,397 | $220,839 |
| 2026-02-19 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Sell | 3,684 | $242,739 |
| 2026-02-11 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Buy | 19,000 | $0 |
| 2025-07-18 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Sell | 2,031 | $119,829 |
| 2025-07-14 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Sell | 2,000 | $115,000 |
| 2025-06-18 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Sell | 2,000 | $104,520 |
| 2025-04-02 | BIODESIX INC (BDSX) | Director | Buy | 26,368 | $0 |
| 2025-02-20 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Sell | 3,136 | $171,163 |
| 2025-02-12 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | Buy | 36,000 | $0 |
Source: SEC Form 4 filings · as of 2026-04-15